Stocksigma LogoStocksigma Logo

Alkem Laboratories Board to Consider Q2 and H1 Results on 12th Nov'26

Alkem Laboratories Limited has informed the exchanges that a meeting of its Board of Directors is scheduled for 12th Nov'26

Alkem Laboratories Board to Consider Q2 and H1 Results on 12th Nov'26

Alkem Laboratories Ltd 路 Intimation 路 12 Nov 2026, 5:30 am

Alkem Laboratories Board to Consider Q2 and H1 Results on 12th Nov'26 Alkem Laboratories Limited has informed the exchanges that a meeting of its Board of Directors is scheduled for 12th Nov'26. The board will, inter alia, consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26.

Original exchange filing (PDF)

More announcements from Alkem Laboratories Ltd

All Alkem Laboratories Ltd announcements